Prostate Cancer Screening Hits the Streets With the 'Man Van'
By Randy Dotinga HealthDay Reporter
TUESDAY, Feb. 18, 2025 -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in disadvantaged neighborhoods of London, researchers report.
A team led by Dr. Masood Moghul of Royal Marsden Hospital in London reported its findings at the American Society of Clinical Oncology's annual Genitorurinary Cancers Symposium in San Francisco last week.
The screening was offered between January 2023 and January 2024. Led by nurses, the roving clinical unit offered prostate-specific antigen (PSA) tests as well as general health check-ups to men who were invited due to their high risk.
Of 3,379 men (average age: 59) who agreed to be screened, 310 had further exams due to suspicion of prostate cancer, and 127 had biopsies. In all, 36.4% of participants were non-white, including 16.7% who were Black men.)
In all, 81 men (2.8%) were diagnosed with clinically significant prostate cancer, and they were managed with various treatments.
One man was diagnosed with bladder cancer, 43 (2%) with diabetes, and 207 (11%) with pre-diabetes.
"With a streamlined and more efficient service we have maintained high uptakes for health checks a willingness to engage with health improvement measures from deprived and ethnic minority groups," the researchers wrote.
In 2020, prostate cancer was the second most commonly diagnosed cancer and the second-leading cause of cancer-related deaths among men worldwide.
In both the United States and the U.K., screening guidelines often emphasize consulting with a doctor to assess a man's prostate cancer risk.
But this approach, researchers said, may create an additional barrier for those already at higher risk, potentially delaying diagnosis until the disease is more advanced and harder to treat.
Research presented at meetings is typically considered preliminary until published in a peer-reviewed journal.
Sources
- American Society of Clinical Oncology meeting, Feb. 13-15, 2025, San Francisco
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Recalled: More Than 67,000 Cases of Deodorant Sold at Dollar Tree, Walmart, and Amazon
TUESDAY, July 22, 2025 — More than 67,000 cases of Power Stick deodorant have been recalled due to an undisclosed manufacturing issue. The recalled deodorants, made by A.P...
Dogs Can Sniff Out Parkinson's Disease, Study Shows
TUESDAY, July 22, 2025 — Dogs’ noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect illicit drug...
For Some, Gluten Intolerance Is Psychological, Study Says
TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.